The involvement of 5-LOX in the chronic inflammatory condition of IBD is evident from the findings of a 3–7-fold increase in 5-LOX expression in the colonic biopsies of patients with active IBD compared to controls and elevated urine levels of LTE4 in patients with active UC and CD [7]. Here, ALOX5 is linked to inflammatory bowel disease.